China Research Development vs Selling General Administrative Analysis

600138 Stock

10.55 0.12 1.15%

China CYTS financial indicator trend analysis is way more than just evaluating China CYTS Tours prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China CYTS Tours is a good investment. Please check the relationship between China CYTS Research Development and its Selling General Administrative accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China CYTS Tours. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China CYTS Tours Research Development account and Selling General Administrative. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between China CYTS's Research Development and Selling General Administrative is -0.32. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Selling General Administrative in the same time period over historical financial statements of China CYTS Tours, assuming nothing else is changed. The correlation between historical values of China CYTS's Research Development and Selling General Administrative is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of China CYTS Tours are associated (or correlated) with its Selling General Administrative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Selling General Administrative has no effect on the direction of Research Development i.e., China CYTS's Research Development and Selling General Administrative go up and down completely randomly.

Correlation Coefficient

-0.32

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Research Development

Selling General Administrative

Most indicators from China CYTS's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China CYTS Tours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China CYTS Tours. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 138.5 M, whereas Selling General Administrative is forecasted to decline to about 890.2 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.6B	1.0B	2.4B	1.8B
Research Development	9.4M	12.7M	7.7M	9.4M

Gross Profit Research Development

China CYTS fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Retained Earnings	Accounts Payable	Cash	Other Assets	Net Receivables	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Long Term Debt	Good Will	Net Tangible Assets	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt
Total Assets		-0.06	0.97	0.95	0.12	0.96	0.59	0.89	0.8	0.86	-0.6	0.86	0.19	0.85	0.82	0.82	0.75	0.66	-0.56	0.8	0.27	0.81	0.87	0.87	0.81	0.9
Other Current Liab	-0.06		0.05	-0.04	0.26	0.0	0.53	0.17	-0.25	0.3	-0.33	0.1	0.73	-0.31	-0.39	-0.09	-0.4	-0.6	0.57	-0.4	0.24	-0.42	-0.37	-0.4	-0.22	-0.31
Total Current Liabilities	0.97	0.05		0.87	0.02	0.91	0.58	0.93	0.73	0.82	-0.59	0.92	0.19	0.85	0.73	0.7	0.74	0.6	-0.56	0.77	0.2	0.75	0.83	0.85	0.81	0.87
Total Stockholder Equity	0.95	-0.04	0.87		0.24	0.99	0.67	0.85	0.84	0.87	-0.59	0.74	0.27	0.74	0.86	0.93	0.65	0.56	-0.48	0.75	0.42	0.78	0.81	0.77	0.76	0.84
Other Liab	0.12	0.26	0.02	0.24		0.25	0.39	-0.1	0.07	0.38	-0.14	0.02	0.65	-0.06	0.15	0.2	-0.07	-0.02	0.12	0.03	0.73	0.18	0.04	-0.08	0.04	0.05
Retained Earnings	0.96	0.0	0.91	0.99	0.25		0.66	0.87	0.8	0.87	-0.56	0.81	0.31	0.76	0.83	0.87	0.65	0.56	-0.49	0.78	0.44	0.8	0.84	0.8	0.81	0.87
Accounts Payable	0.59	0.53	0.58	0.67	0.39	0.66		0.56	0.54	0.86	-0.85	0.45	0.7	0.34	0.35	0.62	0.31	0.04	-0.05	0.25	0.45	0.26	0.26	0.2	0.31	0.3
Cash	0.89	0.17	0.93	0.85	-0.1	0.87	0.56		0.71	0.75	-0.56	0.87	0.16	0.75	0.69	0.73	0.62	0.46	-0.44	0.67	0.17	0.63	0.74	0.77	0.76	0.79
Other Assets	0.8	-0.25	0.73	0.84	0.07	0.8	0.54	0.71		0.72	-0.68	0.62	0.07	0.86	0.89	0.81	0.87	0.72	-0.73	0.82	0.31	0.84	0.81	0.77	0.75	0.79
Net Receivables	0.86	0.3	0.82	0.87	0.38	0.87	0.86	0.75	0.72		-0.81	0.71	0.58	0.63	0.6	0.79	0.56	0.39	-0.3	0.57	0.48	0.6	0.61	0.54	0.58	0.64
Short Term Investments	-0.6	-0.33	-0.59	-0.59	-0.14	-0.56	-0.85	-0.56	-0.68	-0.81		-0.43	-0.4	-0.54	-0.41	-0.59	-0.58	-0.26	0.24	-0.3	-0.15	-0.31	-0.31	-0.29	-0.29	-0.3
Inventory	0.86	0.1	0.92	0.74	0.02	0.81	0.45	0.87	0.62	0.71	-0.43		0.22	0.81	0.66	0.52	0.63	0.6	-0.56	0.78	0.24	0.71	0.8	0.84	0.89	0.86
Other Current Assets	0.19	0.73	0.19	0.27	0.65	0.31	0.7	0.16	0.07	0.58	-0.4	0.22		-0.09	-0.08	0.17	-0.17	-0.28	0.31	-0.03	0.69	0.01	-0.03	-0.15	0.06	0.02
Total Liab	0.85	-0.31	0.85	0.74	-0.06	0.76	0.34	0.75	0.86	0.63	-0.54	0.81	-0.09		0.85	0.58	0.96	0.88	-0.84	0.88	0.09	0.87	0.88	0.93	0.87	0.88
Intangible Assets	0.82	-0.39	0.73	0.86	0.15	0.83	0.35	0.69	0.89	0.6	-0.41	0.66	-0.08	0.85		0.8	0.81	0.78	-0.73	0.84	0.25	0.87	0.85	0.88	0.84	0.86
Common Stock	0.82	-0.09	0.7	0.93	0.2	0.87	0.62	0.73	0.81	0.79	-0.59	0.52	0.17	0.58	0.8		0.55	0.44	-0.38	0.6	0.35	0.65	0.67	0.6	0.56	0.67
Property Plant Equipment	0.75	-0.4	0.74	0.65	-0.07	0.65	0.31	0.62	0.87	0.56	-0.58	0.63	-0.17	0.96	0.81	0.55		0.85	-0.87	0.83	0.05	0.84	0.81	0.83	0.74	0.78
Long Term Debt	0.66	-0.6	0.6	0.56	-0.02	0.56	0.04	0.46	0.72	0.39	-0.26	0.6	-0.28	0.88	0.78	0.44	0.85		-0.84	0.83	0.09	0.84	0.82	0.86	0.76	0.8
Good Will	-0.56	0.57	-0.56	-0.48	0.12	-0.49	-0.05	-0.44	-0.73	-0.3	0.24	-0.56	0.31	-0.84	-0.73	-0.38	-0.87	-0.84		-0.89	-0.14	-0.83	-0.82	-0.79	-0.77	-0.76
Net Tangible Assets	0.8	-0.4	0.77	0.75	0.03	0.78	0.25	0.67	0.82	0.57	-0.3	0.78	-0.03	0.88	0.84	0.6	0.83	0.83	-0.89		0.38	0.97	0.98	0.92	0.93	0.96
Other Stockholder Equity	0.27	0.24	0.2	0.42	0.73	0.44	0.45	0.17	0.31	0.48	-0.15	0.24	0.69	0.09	0.25	0.35	0.05	0.09	-0.14	0.38		0.43	0.36	0.13	0.35	0.34
Deferred Long Term Liab	0.81	-0.42	0.75	0.78	0.18	0.8	0.26	0.63	0.84	0.6	-0.31	0.71	0.01	0.87	0.87	0.65	0.84	0.84	-0.83	0.97	0.43		0.97	0.91	0.87	0.95
Long Term Investments	0.87	-0.37	0.83	0.81	0.04	0.84	0.26	0.74	0.81	0.61	-0.31	0.8	-0.03	0.88	0.85	0.67	0.81	0.82	-0.82	0.98	0.36	0.97		0.95	0.92	0.98
Short Long Term Debt	0.87	-0.4	0.85	0.77	-0.08	0.8	0.2	0.77	0.77	0.54	-0.29	0.84	-0.15	0.93	0.88	0.6	0.83	0.86	-0.79	0.92	0.13	0.91	0.95		0.93	0.97
Total Current Assets	0.81	-0.22	0.81	0.76	0.04	0.81	0.31	0.76	0.75	0.58	-0.29	0.89	0.06	0.87	0.84	0.56	0.74	0.76	-0.77	0.93	0.35	0.87	0.92	0.93		0.95
Short Term Debt	0.9	-0.31	0.87	0.84	0.05	0.87	0.3	0.79	0.79	0.64	-0.3	0.86	0.02	0.88	0.86	0.67	0.78	0.8	-0.76	0.96	0.34	0.95	0.98	0.97	0.95

Click cells to compare fundamentals

China CYTS Account Relationship Matchups

China CYTS fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	16.4B	17.1B	17.4B	17.6B	17.3B	9.4B
Other Current Liab	1.5B	1.8B	931.0M	77.1M	93.2M	88.6M
Total Current Liabilities	6.2B	7.6B	7.3B	6.5B	6.8B	3.7B
Total Stockholder Equity	6.6B	6.3B	6.3B	6.0B	6.2B	3.8B
Other Liab	10.0M	240.1M	5.2M	7.1M	8.1M	7.7M
Retained Earnings	4.1B	3.9B	3.9B	3.4B	3.5B	1.9B
Accounts Payable	1.7B	1.4B	1.4B	1.1B	1.1B	975.9M
Cash	1.0B	1.8B	1.4B	1.2B	1.2B	807.4M
Other Assets	1.2B	1.0B	998.0M	1.1B	1.3B	1.3B
Net Receivables	2.7B	2.2B	2.1B	2.2B	2.3B	1.5B
Inventory	2.4B	2.9B	2.2B	2.1B	2.0B	1.3B
Other Current Assets	939.2M	295.0M	311.8M	191.0M	111.3M	105.7M
Total Liab	7.5B	8.5B	8.8B	9.5B	8.9B	9.4B
Intangible Assets	1.2B	1.2B	1.2B	1.2B	1.2B	1.2B
Property Plant Equipment	4.1B	4.5B	4.7B	5.9B	6.8B	7.1B
Long Term Debt	1.0B	869.7M	617.6M	1.8B	1.4B	1.5B
Net Tangible Assets	5.3B	5.3B	5.1B	5.1B	5.8B	5.3B
Other Stockholder Equity	(22.0M)	(20.4M)	(25.3M)	(27.2M)	(24.5M)	(25.7M)
Deferred Long Term Liab	372.5M	408.7M	349.9M	384.1M	441.7M	385.2M
Short Long Term Debt	2.5B	3.3B	3.4B	3.7B	3.2B	2.6B
Total Current Assets	7.1B	7.5B	6.3B	6.1B	6.4B	6.5B
Non Current Assets Total	9.4B	9.6B	11.1B	11.4B	10.9B	10.3B
Non Currrent Assets Other	223.5M	233.0M	283.9M	239.4M	198.7M	230.2M
Non Current Liabilities Total	1.3B	874.9M	1.5B	2.9B	2.1B	1.4B
Non Current Liabilities Other	10.0M	240.1M	1.4M	1.2M	1.0M	994.5K
Net Debt	2.5B	2.5B	2.6B	4.3B	3.4B	2.8B
Net Invested Capital	10.1B	10.5B	10.4B	11.5B	10.8B	11.0B
Net Working Capital	832.5M	(130.6M)	(961.3M)	(405.3M)	(461.8M)	(438.7M)

Currently Active Assets on Macroaxis

C	Citigroup
GM	General Motors
F	Ford Motor
GM	General Motors
V	Visa Class A

Other Information on Investing in China Stock

Balance Sheet is a snapshot of the financial position of China CYTS Tours at a specified time, usually calculated after every quarter, six months, or one year. China CYTS Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of China CYTS and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which China currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

China Research Development vs Selling General Administrative Analysis

Research Development vs Selling General Administrative

Research Development vs Selling General Administrative Correlation Analysis

Correlation Coefficient

Research Development

Selling General Administrative

China CYTS fundamental ratios Correlations

China CYTS Account Relationship Matchups

High Positive Relationship

High Negative Relationship

China CYTS fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in China Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 0.99	Total Stockholder Equity
Long Term Investments	+ 0.98	Net Tangible Assets
Short Term Debt	+ 0.98	Long Term Investments
Total Current Liabilities	+ 0.97	Total Assets
Deferred Long Term Liab	+ 0.97	Net Tangible Assets
Long Term Investments	+ 0.97	Deferred Long Term Liab

Net Tangible Assets	- 0.89	Good Will
Good Will	- 0.87	Property Plant Equipment
Short Term Investments	- 0.85	Accounts Payable
Good Will	- 0.84	Long Term Debt
Good Will	- 0.84	Total Liab
Deferred Long Term Liab	- 0.83	Good Will